It is now widely recognized that the MYC transcription factor is a dominant oncogenic driver in a majority of human T-ALL and is often activated downstream of NOTCH1 [71], and targeting the NOTCH/MYC pathway can lead to cell death by increasing the apoptosis of tumor cells. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.